D.E. Shaw & Co’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.47M Buy
923,644
+907,808
+5,733% +$7.34M 0.01% 1212
2025
Q1
$133K Buy
+15,836
New +$133K ﹤0.01% 2819
2024
Q3
Sell
-89,895
Closed -$571K 3140
2024
Q2
$571K Sell
89,895
-136,309
-60% -$866K ﹤0.01% 2429
2024
Q1
$1.37M Sell
226,204
-439,832
-66% -$2.67M ﹤0.01% 1962
2023
Q4
$4.04M Sell
666,036
-208,880
-24% -$1.27M ﹤0.01% 1337
2023
Q3
$3.69M Buy
874,916
+252,690
+41% +$1.07M ﹤0.01% 1377
2023
Q2
$1.93M Sell
622,226
-7,883
-1% -$24.4K ﹤0.01% 1767
2023
Q1
$876K Sell
630,109
-58,728
-9% -$81.6K ﹤0.01% 2269
2022
Q4
$1.37M Buy
688,837
+427,987
+164% +$852K ﹤0.01% 2250
2022
Q3
$527K Buy
260,850
+71,923
+38% +$145K ﹤0.01% 2852
2022
Q2
$601K Sell
188,927
-65,072
-26% -$207K ﹤0.01% 2965
2022
Q1
$1.06M Buy
253,999
+95,977
+61% +$400K ﹤0.01% 2836
2021
Q4
$757K Buy
158,022
+139,980
+776% +$671K ﹤0.01% 2895
2021
Q3
$96K Buy
+18,042
New +$96K ﹤0.01% 3395
2021
Q2
Sell
-122,774
Closed -$826K 3517
2021
Q1
$826K Buy
+122,774
New +$826K ﹤0.01% 2286
2020
Q1
Sell
-224,285
Closed -$1.08M 2648
2019
Q4
$1.08M Buy
224,285
+125,081
+126% +$603K ﹤0.01% 1882
2019
Q3
$288K Sell
99,204
-59,475
-37% -$173K ﹤0.01% 2295
2019
Q2
$1.14M Sell
158,679
-265,301
-63% -$1.9M ﹤0.01% 1832
2019
Q1
$6.01M Sell
423,980
-378,882
-47% -$5.37M 0.01% 1072
2018
Q4
$10.9M Buy
802,862
+56,890
+8% +$770K 0.02% 769
2018
Q3
$16.6M Sell
745,972
-246,020
-25% -$5.46M 0.02% 640
2018
Q2
$16.3M Buy
+991,992
New +$16.3M 0.02% 642